Chronic obstructive pulmonary disease (COPD) is a group of diseases that affect the lungs. The disease makes it difficult to breath and progressively gets worse. About 15 million Americans have been ...

By Linda Naa Deide AryeeteyCape Town, March 6, GNA – The World Health Organisation (WHO) General Special Envoy on Chronic ...

Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need ...

Patients with chronic obstructive pulmonary disease (COPD) and muscle loss phenotype (MLP) have an elevated risk of all-cause or COPD-related mortality. Patients with chronic obstructive pulmonary ...

Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that cause breathing difficulty and coughing. Both conditions share similar symptoms. Understanding their ...

Miami (January 21, 2025) – Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S.

Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...

Gordon Stewart-Harrison recalls his first experience with chronic obstructive pulmonary disease (COPD) when he was shoveling snow on his driveway. After just a few moments, he was completely out of ...

Patients with COPD who travel to high altitudes have an estimated PaO2 decrease of 0.84 kPa with each 1000 meter of altitude gain. High-altitude travel in patients with chronic obstructive pulmonary ...

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An injectable interleukin ...